Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sorted Group renews contract with M&S

(Sharecast News) - Sorted Group said on Thursday that it has renewed its contract with Marks & Spencer until September 2028, extending a partnership that it said underpins the retailer's delivery operations with Sorted's cloud-based technology. The AIM-traded firm said M&S had used Sorted's carrier management platform 'Ship' and post-purchase software 'Track' since 2021 to integrate carrier services across distribution centres and manage customer delivery communications.

It said the renewal continued the commercial terms of the existing agreement and represented Sorted's largest contract to date.

"M&S has a long-standing reputation for outstanding customer experience," said executive chairman Simon Wilkinson.

"We are pleased to have supported their ever-growing online ambitions for many years now and the previous renewal of M&S's contract with Sorted from 12-months, announced on 27 March 2024, to this renewal - running through to 22 September 2028, a term of just over three years - further strengthens our partnership and represents the largest for Sorted to date."

At 1547 BST, shares in Sorted Group Holdings were up 112.11% at 40.3p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.